Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries.
Perelman School of Medicine
Perelman School of Medicine’s Mitesh Patel is quoted about a Penn study on doctor fatigue and patient care.
Dominic A. Sisti of the Perelman School of Medicine shares his opinion on using hallucinogenic drugs to treat depression.
The latest results of clinical trials of more than 125 patients testing an investigational personalized cellular therapy known as CTL019 will be presented by a University of Pennsylvania research team at the 56th American Society of Hematology Annual Meeting and Exposition.
Quitting smoking sets off a series of changes in the brain that Penn Medicine researchers say may better identify smokers who will start smoking again—a prediction that goes above and beyond today’s clinical or behavioral tools for assessing relapse risk.
Caryn Lerman of the Perelman School of Medicine talks about researching regions of the brain that may help predict succ
Bob Siman of the Perelman School of Medicine discusses a protein, SNTF, which might be able to predict the severity of